ARCHIVES

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988